Skip to content

Income Tax at other companies

Pfizer logo
PfizerPFE
$461M+344%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$347K-99.5%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$3.99M+23.6%
Mannkind logo
MannkindMNKD
$253K-44.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$20.5M+40.9%
Celcuity logo
CelcuityCELC
$0

Segments

By segment

See full
Single Reportable$1.6K0.0%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's income tax?
Capricor Therapeutics (CAPR) reported income tax of $0 in Q1 2026.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.